Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2022
Speciality: Early-stage MedTech Investments. Portfolio of high-integrity entrepreneurs that have the potential to build exceptional businesses, and shape healthcare of tomorrow. Value creation through capital deployment + active Board positions. Exclusive EU deal sourcing in collaboration with our network of trustees, and industry partnerships.
2017
Supporting Founding Teams and Boards through trusted Healthcare & Life Science expert guidance, including: Strategic, Clinical, Commercial, Finance, Governance and Growth aspects.
2018
BioComp Industries specializes in Osseointegrated Implant Systems and Surgical Instruments for intra-oral (BioComp Dental) and CranioFacial Reconstruction (AHEAD CranioFacial). At present AHEAD Implant is the leading Single-Implant based CranioFacial system across Europe and Scandinavia, with a strong network of clinicians and local distribution partners.
2019
Supporting a broad range of ventures, including: Carmel Diagnostics (IL), Salvia (NL), KOLLESTEE Medikal (TR), OramaVR (CH), Tinybots (NL), Glucoset (NO), CYTO365 (SE), Vbionic (PL), Immunobiogram (ES), Sava (UK), Dermagnostix (DE), Precordior (FI), Instituto de Medicina Molecular (PT), Archeon Medical (FR), ...
2020
2023
2020 - 2023
Focus on Advanced Wound Care - FeelTect´s lead product, Tight Alright, is a specialised connected-health device for compression therapy. Developed, tested and FDA/MDR regulated for the millions of people worldwide with venous leg ulcers (VLUs).
2020
2022
The company is focused on improving ventilation quality in pre-hospital care and emergency medical services. Archeon Medical offers practical, easy-to-use, and intuitive products for all emergency caregivers, offering clients real-time feedback on the quality of ventilation given to the patient.
2020 - 2022
2022
2022
Innitius develops medical devices combining novel technology (Torsional Waves) with AI, for the diagnosis of pathologies associated with change in a woman’s cervical tissue consistency. Innitius´lead product is FineBirth (Diagnosis of Threatened Preterm Labour).
2017
2019
2020 - 2024
2017 - 2019
2018
AuM allocated. Activities limited to portfolio monitoring.
2018 - 2020
2018 - 2020